XELA REDERM^® 1.8%

Redermalization is an innovative method that helps effectively counteract skin aging and rebuild it. It influences all three basic mechanisms of skin aging, namely:

• regulates biochemical and physiological processes in cells,
• effectively blocks free radicals through the influence of succinic acid,
• prevents skin dehydration - action of hyaluronic acid.

For the effective implementation of the redermalization procedure, Hyalual Institute has created a line of new generation injection preparations Xela Rederm^®.

The particular feature of these preparations is the unique formula utilizing the synergistic action of sodium succinate and hyaluronic acid.

Sodium Succinate causes:

• activation of cells to function and inhibits processes leading to their death,
• stimulation of synthesis of basic structural proteins of the skin: collagen and elastin,
• increased oxygen delivery to tissues.

Action of Sodium Succinate prevents skin aging and regenerates it, resulting in:

• improvement of skin texture and appearance,
• increased elasticity and firmness,
• lifting effect,
• removal of discoloration,
• reduction in the depth and size of wrinkles,
• skin nourishment.

Meanwhile, Hyaluronic Acid prevents skin dehydration, thereby moisturizing it by balancing the deficit of hyaluronic acid in tissues.

Xela Rederm^® Treatment should consist of three procedures performed every two weeks. To maintain the effect, repeat the treatment after 6-9 months - 1 treatment per month or another series of treatments.

Administration Techniques:

• on the face - linear method,
• on the body - nodular method.

INDICATIONS

• patient age: from 35 years,
• severe age-related changes (atony, atrophy, ptosis),
• wrinkles (mimetic and gravitational) of varying depth,
• dry skin,
• preparation for contour plastic surgery.

COMPOSITION

Non-crosslinked hyaluronic acid: 1.8% (18 mg/ml)

Succinic acid (sodium succinate): 1.6% (16 mg/ml)

Lidocaine: -

PACKAGING

1 glass syringe with 2ml of the preparation,

2 needles 30G 13mm

CONTRAINDICATIONS

• in areas or near areas with inflammatory conditions or skin infections (acne, rash),
• tendency to develop hypertrophic scars,
• hypersensitivity to hyaluronic acid, mannitol, lidocaine hydrochloride, or locally applied anesthetics,
• porphyria patients,
• reduced blood clotting,
• allergy, including to chromium and nickel,
• taking blood-thinning medications (e.g., aspirin, Polocard),
• pregnant, breastfeeding women, and children,
• menstruation,
• taking antibiotics (up to 2 weeks after completing antibiotic therapy).

TREATMENT METHOD

The procedure should be performed by a specialist familiar with the administration method.

Xela rederm is intended for subcutaneous administration only, on a bump. The treatment area should be massaged after injection to ensure proper distribution of the product.

Before the procedure, patients should be informed about possible side effects and risks. The area to be treated should be thoroughly disinfected. The product should be injected slowly into the skin.

After the procedure, slight swelling, redness, or minor bruising may occur, which disappear within several hours to several days.

STORAGE

Store at temperatures between 2 and 25°C. Protect from sunlight and freezing. Do not freeze. Keep out of reach of children.

MANUFACTURER

Hyalual Institute

Product for use by professionals only. By purchasing, you declare that you are a physician or a cosmetologist trained in aesthetic medicine.

Before use, read the leaflet included in the package.